Stoneridge (SRI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
9 Apr, 2026Executive summary
Annual meeting scheduled for May 19, 2026, with virtual participation available to shareholders.
Shareholders are encouraged to review proxy materials online or request copies before voting.
Voting matters and shareholder proposals
Election of nine directors, with board recommendations for each nominee.
Ratification of Ernst & Young LLP as independent registered public accounting firm for 2026.
Advisory approval of 2025 executive compensation (say-on-pay) is up for vote.
Amendment to the 2025 Long-Term Incentive Plan to increase shares available for issuance.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Director nominees include Aron R. English, Ira C. Kaplan, Kim Korth, William M. Lasky, Natalia Noblet, Carsten J. Reinhardt, Sheila Rutt, Frank S. Sklarsky, and James Zizelman.
Latest events from Stoneridge
- Q2 2026 revenue up 15.1%, net loss narrowed, and guidance reaffirmed on strong vehicle demand.SRI
Q2 2026 - Growth driven by MirrorEye, regulatory tailwinds, and operational improvements amid macro softness.SRI
Stephens 26th Annual Investment Conference | NASH2024 - All proposals, including director elections and compensation, were approved without shareholder questions.SRI
AGM 2026 - Q1 2026 saw 9.2% sales growth, margin gains, record MirrorEye sales, and net debt reduction.SRI
Q1 2026 - Annual meeting covers director elections, auditor ratification, compensation, and ESG oversight.SRI
Proxy filing - 2025 outperformed end markets with 69%–70% MirrorEye growth and strong 2026 targets.SRI
Q4 2025 - Control Devices sold for $59M to focus on advanced electronics and reduce debt.SRI
Status update - Sales and earnings fell on market weakness, but MirrorEye and cash flow showed improvement.SRI
Q3 2024 - Q2 2024 delivered margin gains and improved profitability, with key OEM launches accelerating.SRI
Q2 2024